22-May-2019 | D | Zim Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2019, inter alia, has recommended Dividend at the rate of Rs. 0.50 per share for the financial year 2018-19. | 19-Sep-2019 | |
14-Aug-2018 | D | Zim Laboratories Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on August 14, 2018, inter alia, has approved the following:
Recommendation of 10% final Dividend on equity shares of Rs. 10/- each i.e. Re 1/- per equity share, for the year ended March 31, 2018. | 03-Sep-2018 | |
12-Dec-2022 | B | 2:1 Bonus Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, ZIM Laboratories Limited has fixed the Record Date for the purpose of Bonus Issue. The transactions in the Equity Shares of the Company would be on an Ex-Bonus basis with effect from the under mentioned date :
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME
& CODE
ZIM Laboratories Limited
(541400)
RECORD DATE
22/12/2022
PURPOSE
Issue of 2 (Two) Bonus Equity Shares of Rs.10/- each for every 1 (One) existing Equity Share of Rs.10/- each held.
Ex-Bonus basis from Date & Sett. No.
22/12/2022
DR-682/2022-2023
(As Per BSE Notice Dated on 19.12.2022) | 22-Dec-2022 | 2:1 |
28-Sep-2018 | B | Trading Members of the Exchange are hereby informed that, Zim Laboratories Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Zim Laboratories Limited
(541400)
RECORD DATE
06/10/2018
PURPOSE
Issue of 01 (One) Bonus equity share of Rs.10/- each for every 01 (One) existing equity share of Rs.10/- each held.
Ex-Bonus basis from Date & Sett. No.
04/10/2018 DR-130/2018-2019
Trading Members of the Exchange are requested to take of it. | 06-Oct-2018 | 1:1 |
01-Apr-2024 | BC | Mathew Cyriac | 27-Mar-2024 | |
22-Jan-2024 | BC | Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve the unaudited Financial Results (Standalon | 29-Jan-2024 | |
28-Dec-2023 | BC | Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed a copy of the Postal Ballot notice dated 23rd December 2023 along with explanatory statement for seeking approval of mem | 28-Jan-2024 | |
20-Dec-2023 | BC | Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2023 inter alia to consider and approve the ZIM Laboratories Employee Stock Option | 23-Dec-2023 | |
09-Nov-2023 | BC | Mathew Cyriac
| 07-Nov-2023 | |
Announcement Date22-May-2019
Ex Dividend Date19-Sep-2019
Dividend(%)5
Announcement Date14-Aug-2018
Ex Dividend Date03-Sep-2018
Dividend(%)10
Record Date22-Dec-2022
Ex-Bonus Date22-Dec-2022
Ratio2:1
Record Date06-Oct-2018
Ex-Bonus Date04-Oct-2018
Ratio1:1
No Split has been declared by ZIMLAB
RightsNo Rights has been declared by ZIMLAB
Book Closure
27-Mar-2024 | - | Mathew Cyriac |
29-Jan-2024 | - | Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve the unaudited Financial Results (Standalon |
28-Jan-2024 | 01 Jan'1900 | Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed a copy of the Postal Ballot notice dated 23rd December 2023 along with explanatory statement for seeking approval of mem |
23-Dec-2023 | - | Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2023 inter alia to consider and approve the ZIM Laboratories Employee Stock Option |
07-Nov-2023 | - | Mathew Cyriac
|